Auris Medical

Biotech

Auris Medical pivots to RNA with Trasir Therapeutics buyout

It’s all-change at Auris Medical as it ditches its leaking pipeline, changes it name and its ticker as it picks up an RNA biotech.
Ben Adams Jun 3, 2021 9:40am

EMA gives go-ahead to new Auris trial for hearing loss drug

May 7, 2018 12:00pm

Auris’ tinnitus drug fails in phase 3 again 

Mar 14, 2018 8:15am

Auris Medical hit by another late-stage trial flop

Nov 28, 2017 8:59am

Second Nasdaq compliance notice adds to Auris’ woes

Aug 25, 2017 6:55am

EuroBiotech:​​​ ​​​More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note

Feb 16, 2017 9:22am